186 related articles for article (PubMed ID: 10341503)
1. Clinical and laboratory study of kala-azar in children in Nepal.
Singh K; Singh R; Parija SC; Faridi MM; Bhatta N
J Trop Pediatr; 1999 Apr; 45(2):95-7. PubMed ID: 10341503
[TBL] [Abstract][Full Text] [Related]
2. A thirty day course of sodium stibogluconate for treatment of Kala-azar in Nepal.
Karki P; Koirala S; Parija SC; Hansdak SG; Das ML
Southeast Asian J Trop Med Public Health; 1998 Mar; 29(1):154-8. PubMed ID: 9740292
[TBL] [Abstract][Full Text] [Related]
3. Post-kala-azar dermal leishmaniasis (PKDL): the first case report from Nepal.
Karki P; Koirala S; Parija SC; Sethi M; Das ML
Southeast Asian J Trop Med Public Health; 2003 Mar; 34(1):22-3. PubMed ID: 12971510
[TBL] [Abstract][Full Text] [Related]
4. Post-kala-azar dermal leishmaniasis in the Sudan: clinical presentation and differential diagnosis.
Zijlstra EE; Khalil EA; Kager PA; El-Hassan AM
Br J Dermatol; 2000 Jul; 143(1):136-43. PubMed ID: 10886148
[TBL] [Abstract][Full Text] [Related]
5. Changing Epidemiology: A New Focus of Kala-azar at High-Altitude Garhwal Region of North India.
Kumar Bhat N; Ahuja V; Dhar M; Ahmad S; Pandita N; Gupta V; Chandra S
J Trop Pediatr; 2017 Apr; 63(2):104-108. PubMed ID: 27582128
[TBL] [Abstract][Full Text] [Related]
6. Comparison of treatment regimens of kala-azar based on culture & sensitivity of amastigotes to sodium antimony gluconate.
Thakur CP; Thakur S; Narayan S; Sinha A
Indian J Med Res; 2008 Jun; 127(6):582-8. PubMed ID: 18765878
[TBL] [Abstract][Full Text] [Related]
7. Kala-azar in Uttar Pradesh--a study of 66 patients.
Mittal V; Singh VK; Ichhpujani RL
J Commun Dis; 2002 Mar; 34(1):43-9. PubMed ID: 12718341
[TBL] [Abstract][Full Text] [Related]
8. Treatment of visceral leishmaniasis in south-eastern Nepal: decreasing efficacy of sodium stibogluconate and need for a policy to limit further decline.
Rijal S; Chappuis F; Singh R; Bovier PA; Acharya P; Karki BM; Das ML; Desjeux P; Loutan L; Koirala S
Trans R Soc Trop Med Hyg; 2003; 97(3):350-4. PubMed ID: 15228258
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B and C viral infections in Indian kala-azar patients receiving injectable anti-leishmanial drugs: a community-based study.
Singh S ; Kumar J; Singh R; Dwivedi SN
Int J Infect Dis; 2000; 4(4):203-8. PubMed ID: 11231183
[TBL] [Abstract][Full Text] [Related]
10. Clinical aspects of kala-azar in children from the Sudan: a comparison with the disease in adults.
Zijlstra EE; Ali MS; el-Hassan AM; el-Toum IA; Satti M; Ghalib HW
J Trop Pediatr; 1992 Feb; 38(1):17-21. PubMed ID: 1315397
[TBL] [Abstract][Full Text] [Related]
11. Post kala-azar ocular leishmaniasis.
el Hassan AM; Khalil EA; el Sheikh EA; Zijlstra EE; Osman A; Ibrahim ME
Trans R Soc Trop Med Hyg; 1998; 92(2):177-9. PubMed ID: 9764325
[TBL] [Abstract][Full Text] [Related]
12. Kala-azar in Afghanistan.
Singh M; Arya LS; Aram GN; Fazal MI; Qureshi MA; Goel RG
J Trop Med Hyg; 1982 Oct; 85(5):201-4. PubMed ID: 7176002
[TBL] [Abstract][Full Text] [Related]
13. Comparison of generic and proprietary sodium stibogluconate for the treatment of visceral leishmaniasis in Kenya.
Moore E; O'Flaherty D; Heuvelmans H; Seaman J; Veeken H; de Wit S; Davidson RN
Bull World Health Organ; 2001; 79(5):388-93. PubMed ID: 11417033
[TBL] [Abstract][Full Text] [Related]
14. Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India.
Singh RP; Picado A; Alam S; Hasker E; Singh SP; Ostyn B; Chappuis F; Sundar S; Boelaert M
Trop Med Int Health; 2012 Nov; 17(11):1345-8. PubMed ID: 22882665
[TBL] [Abstract][Full Text] [Related]
15. Post-kala-azar dermal leishmaniasis mimicking leprosy: experience with 4 patients, with some unusual features in 1.
Dhar S; Kaur I; Dawn G; Sehgal S; Kumar B
Lepr Rev; 1995 Sep; 66(3):250-6. PubMed ID: 7500822
[TBL] [Abstract][Full Text] [Related]
16. [Visceral leishmaniasis (kala-azar). A rare differential diagnosis of splenomegaly and pancytopenia].
Baldus M; Schleiffer T; Brass H
Dtsch Med Wochenschr; 1989 Dec; 114(48):1876-81. PubMed ID: 2555125
[TBL] [Abstract][Full Text] [Related]
17. PCR for diagnosis and assessment of cure in kala-azar patients in Bangladesh.
Salam MA; Mondal D; Kabir M; Ekram AR; Haque R
Acta Trop; 2010 Jan; 113(1):52-5. PubMed ID: 19769932
[TBL] [Abstract][Full Text] [Related]
18. Seroepidemiological study on kala-azar in Baringo District, Kenya.
Jahn A; Lelmett JM; Diesfeld HJ
J Trop Med Hyg; 1986 Apr; 89(2):91-104. PubMed ID: 3021967
[TBL] [Abstract][Full Text] [Related]
19. Epidemiological study of kala-azar by direct agglutination test in two rural communities of eastern Nepal.
Koirala S; Karki P; Das ML; Parija SC; Karki BM
Trop Med Int Health; 2004 Apr; 9(4):533-7. PubMed ID: 15078273
[TBL] [Abstract][Full Text] [Related]
20. Kala-azar: experience from a non-endemic area in India.
Chandra J; Anand V; Patwari AK; Mandal RN; Aneja S; Sharma D
J Trop Pediatr; 1995 Oct; 41(5):298-300. PubMed ID: 8531263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
